☰

Ian R. Hardy, Ph.D. - Publications

Affiliations: 
2010 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Immunology
Tree Info Grants Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Wemlinger SM, Parker Harp CR, Yu B, Hardy IR, Seefeldt M, Matsuda J, Mingueneau M, Spilker KA, Cameron TO, Larrick JW, Getahun A, Cambier JC. Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model. Journal of Immunology (Baltimore, Md. : 1950). 208: 1566-1584. PMID 35321883 DOI: 10.4049/jimmunol.2101056  0.461
2020 Hardy IR, Schamel WW, Baeuerle PA, Getts DR, Hofmeister R. Implications of T cell receptor biology on the development of new T cell therapies for cancer. Immunotherapy. PMID 31902264 DOI: 10.2217/imt-2019-0046  0.326
2018 Viaud S, Ma JSY, Hardy IR, Hampton EN, Benish B, Sherwood L, Nunez V, Ackerman CJ, Khialeeva E, Weglarz M, Lee SC, Woods AK, Young TS. Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory. Proceedings of the National Academy of Sciences of the United States of America. PMID 30373813 DOI: 10.1073/Pnas.1810060115  0.355
2016 Rodgers DT, Mazagova M, Hampton EN, Cao Y, Ramadoss NS, Hardy IR, Schulman A, Du J, Wang F, Singer O, Ma J, Nunez V, Shen J, Woods AK, Wright TM, et al. Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies. Proceedings of the National Academy of Sciences of the United States of America. 113: E459-68. PMID 26759369 DOI: 10.1073/Pnas.1524155113  0.448
2014 Hardy IR, Anceriz N, Rousseau F, Seefeldt MB, Hatterer E, Irla M, Buatois V, Chatel LE, Getahun A, Fletcher A, Cons L, Pontini G, Hertzberg NA, Magistrelli G, Malinge P, et al. Anti-CD79 antibody induces B cell anergy that protects against autoimmunity. Journal of Immunology (Baltimore, Md. : 1950). 192: 1641-50. PMID 24442438 DOI: 10.4049/Jimmunol.1302672  0.499
2012 O'Brien RL, Chain JL, Aydintug MK, Bohrer-Kunter D, Huang Y, Hardy IR, Cambier JC, Lahmers K, Nuhsbaum T, Davidson R, Sun D, Born WK. αβ TCR⁺ T cells, but not B cells, promote autoimmune keratitis in b10 mice lacking γδ T cells. Investigative Ophthalmology & Visual Science. 53: 301-8. PMID 22199243 DOI: 10.1167/Iovs.11-8855  0.425
2009 Young RM, Hardy IR, Clarke RL, Lundy N, Pine P, Turner BC, Potter TA, Refaeli Y. Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target. Blood. 113: 2508-16. PMID 18981293 DOI: 10.1182/Blood-2008-05-158618  0.383
Show low-probability matches.